For hospital emergency departments, the arrival of patients contaminated by weaponized chemicals represents one of the most demanding and least-rehearsed mass casualty scenarios in clinical preparedness planning. Closing a critical gap in that preparedness, the World Health Organization (WHO) published a revised interim guidance document in April 2026, Initial Clinical Management of Patients Exposed to Weaponized Chemicals, updating protocols first issued in January 2014. The revision was funded by Canada’s Weapons Threat Reduction Program and developed with technical input from experts at Newcastle University, the Technical University of Munich, and several leading clinical institutions across Europe.
The guidance is explicitly aimed at health care workers at the facility level — the clinicians, emergency physicians, and nursing staff who may be the first medical professionals to receive casualties from a chemical incident, often before the nature of the agent is known. It covers the full clinical response chain from initial patient screening through decontamination, triage, and agent-specific treatment protocols.
Life-Saving Treatment Before Decontamination
A core principle running through the document is that life-saving treatment takes priority over decontamination. The guidance adopts an all-hazards sequential framework — addressing catastrophic hemorrhage and airway management before decontamination — recognizing that delaying treatment for a patient in cardiorespiratory arrest may cost more lives than the contamination risk itself. At the same time, it stresses that all patients presenting after a suspected chemical attack should be treated as contaminated by default, including those exposed only to gases or vapors who may show no visible signs of contamination.
Decontamination Protocols for Resource-Limited Settings
On decontamination, the document details the “blot, disrobe, rinse, dry” technique, a five-step wet decontamination method requiring minimal equipment and training. Critically, it recommends that decontamination occur outside health care facilities prior to patient entry, with clearly marked and cordoned decontamination zones under the control of security personnel. Clothing removal alone is identified as a highly effective intervention. The guidance also addresses practical challenges frequently overlooked in planning, including maintaining patient dignity, preventing hypothermia, managing communication barriers, and accommodating patients with disabilities.
The triage section provides separate clinical flowcharts for adults and pediatric patients in two weight categories, structured for use in both mass casualty events and resource-limited settings. For rapid clinical assessment, the document introduces the CRESS acronym — Consciousness, Respiration, Eyes, Secretions, Skin — as a quick screening tool for identifying the class of chemical agent involved.
Agent-Specific Treatment Protocols, Including Novichok and Synthetic Opioids
Treatment protocols cover the major categories of weaponized chemicals: nerve agents (including Novichok agents), blister agents such as sulfur mustard and lewisite, cyanide, lung irritants including chlorine and phosgene, incapacitating agents, opioid-based agents such as fentanyl analogues and nitazenes, riot control agents, and white phosphorus. Each section includes specific antidote regimens with dosing for both adults and children, alongside supportive care guidance. Notably, the 2026 update incorporates recent clinical evidence on Novichok poisoning, updated opioid incapacitant guidance reflecting the growing threat posed by synthetic opioids, and a new section on white phosphorus — a munition seeing renewed use in contemporary conflicts.
Why This Matters for Hospital Preparedness and Clinical Mass Casualty Response
For hospital administrators, emergency physicians, infection control officers, and clinical planners, this guidance fills a practical gap that traditional frameworks often leave unaddressed: what to do at the facility level when chemically contaminated patients arrive, potentially before any official notification that a chemical incident has occurred. The document’s emphasis on resource-adaptable protocols — decontamination techniques that require only basic equipment, triage flowcharts usable without specialized training, and antidote regimens with clear dosing for both adults and children — makes it directly actionable for hospital emergency departments.
The inclusion of updated guidance on synthetic opioids such as fentanyl analogues and nitazenes as potential incapacitating agents is particularly relevant for clinical audiences, given that these substances already present in civilian emergency medicine contexts. Likewise, the updated Novichok and white phosphorus sections reflect the realities of what clinical teams may encounter in patients evacuated from active conflict zones.
For health systems engaged in mass casualty planning, chemical terrorism preparedness, or the clinical management of CBRNE events, this WHO document provides an evidence-based, globally applicable reference that is freely available and designed for direct integration into facility-level protocols.
Sources and further reading:
Initial Clinical Management of Patients Exposed to Weaponized Chemicals – World Health Organization (April 2026)